Wikidata

(Q61894429)

English

A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
RIVAL (English)
0 references
title
Development of New Geographic Atrophy in Patients With Neovascular (Wet) Age-related Macular Degeneration: a Comparison of Ranibizumab and Aflibercept (English)
0 references
medical condition
macular degeneration
0 references
atrophy
0 references
sponsor
Novartis
0 references
country
Australia
0 references
start time
11 April 2014
0 references
end time
15 November 2017
0 references
number of participants
281
0 references
research site
Novartis
0 references
minimum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61894429&oldid=2169549486"